Use of mTOR inhibitor as prophylaxis for cytomegalovirus disease after kidney transplantation: A natural experiment.

Marina Pontelo CristelliClaudia Rosso FelipePaulo Sergio de Souza PrizmicVega Figueiredo Dourado de AzevedoLaila Almeida VianaMelissa Gaspar TavaresDaniel Wagner de Castro Lima SantosMayara Ivani de PaulaJose Osmar Medina-PestanaHélio Tedesco Silva-Junior

Published in: Clinical transplantation (2019)

This study suggests that everolimus-containing immunosuppressive regimen reduces the need for preventive strategies for CMV infection in the majority of kidney transplant recipients, reducing antiviral drug-associated toxicities and healthcare-related expenditures.

Keyphrases

healthcare
epstein barr virus
health insurance
emergency department
drug induced
social media
health information
adverse drug